These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1128 related items for PubMed ID: 25393718

  • 21. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study.
    Zhai X, Guo Y, Qian X.
    Med Sci Monit; 2020 Jun 02; 26():e922675. PubMed ID: 32483109
    [Abstract] [Full Text] [Related]

  • 22. Update on nodal staging in non-small cell lung cancer with integrated positron emission tomography/computed tomography: a meta-analysis.
    Pak K, Park S, Cheon GJ, Kang KW, Kim IJ, Lee DS, Kim EE, Chung JK.
    Ann Nucl Med; 2015 Jun 02; 29(5):409-19. PubMed ID: 25655120
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Improving diagnostic performance of 18F-FDG-PET/CT for assessment of regional nodal involvement in non-small cell lung cancer.
    Yang DD, Mirvis E, Goldring J, Patel ARC, Wagner T.
    Clin Radiol; 2019 Oct 02; 74(10):818.e17-818.e23. PubMed ID: 31420186
    [Abstract] [Full Text] [Related]

  • 25. [Utility of PET/CT for mediastinal staging of non-small cell lung cancer in stage III (N2)].
    Sánchez Sánchez R, Rodríguez Fernández A, Gómez Río M, Alkurdi Martínez A, Castellón Rubio VE, Ramos Font C, Sánchez-Palencia Ramos A, Delgado Pérez JR, Llamas Elvira JM.
    Rev Esp Med Nucl; 2011 Oct 02; 30(4):211-6. PubMed ID: 21514978
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Smailagic N, Vacante M, Hyde C, Martin S, Ukoumunne O, Sachpekidis C.
    Cochrane Database Syst Rev; 2015 Jan 28; 1(1):CD010632. PubMed ID: 25629415
    [Abstract] [Full Text] [Related]

  • 29. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.
    Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, Chan JK, Owens DK.
    Ann Intern Med; 2003 Dec 02; 139(11):879-92. PubMed ID: 14644890
    [Abstract] [Full Text] [Related]

  • 30. The diagnostic ability of 18F-FDG PET/CT for mediastinal lymph node staging using 18F-FDG uptake and volumetric CT histogram analysis in non-small cell lung cancer.
    Lee JW, Kim EY, Kim DJ, Lee JH, Kang WJ, Lee JD, Yun M.
    Eur Radiol; 2016 Dec 02; 26(12):4515-4523. PubMed ID: 26943133
    [Abstract] [Full Text] [Related]

  • 31. Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer.
    Bryant AS, Cerfolio RJ, Klemm KM, Ojha B.
    Ann Thorac Surg; 2006 Aug 02; 82(2):417-22; discussion 422-3. PubMed ID: 16863739
    [Abstract] [Full Text] [Related]

  • 32. FDG-PET/CT imaging for mediastinal staging in patients with potentially resectable non-small cell lung cancer.
    Schmidt-Hansen M, Baldwin DR, Zamora J.
    JAMA; 2015 Apr 14; 313(14):1465-6. PubMed ID: 25871673
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Thoracic imaging tests for the diagnosis of COVID-19.
    Salameh JP, Leeflang MM, Hooft L, Islam N, McGrath TA, van der Pol CB, Frank RA, Prager R, Hare SS, Dennie C, Spijker R, Deeks JJ, Dinnes J, Jenniskens K, Korevaar DA, Cohen JF, Van den Bruel A, Takwoingi Y, van de Wijgert J, Damen JA, Wang J, Cochrane COVID-19 Diagnostic Test Accuracy GroupNIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK., McInnes MD.
    Cochrane Database Syst Rev; 2020 Sep 30; 9():CD013639. PubMed ID: 32997361
    [Abstract] [Full Text] [Related]

  • 35. Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy.
    Manzotti C, Casazza G, Stimac T, Nikolova D, Gluud C.
    Cochrane Database Syst Rev; 2019 Jul 05; 7(7):CD012546. PubMed ID: 31283001
    [Abstract] [Full Text] [Related]

  • 36. Is FDG-PET/CT used correctly in the combined approach for nodal staging in NSCLC patients?
    Simsek FS, Comak A, Asik M, Kuslu D, Balci TA, Ulutas H, Koroglu R, Kekilli E, Akatli A, Elmali F, Yalcin NC, Akyol H.
    Niger J Clin Pract; 2020 Jun 05; 23(6):842-847. PubMed ID: 32525121
    [Abstract] [Full Text] [Related]

  • 37. False-positivity of mediastinal lymph nodes has negative effect on survival in potentially resectable non-small cell lung cancer.
    Iskender I, Kadioglu SZ, Cosgun T, Kapicibasi HO, Sagiroglu G, Kosar A, Kir A.
    Eur J Cardiothorac Surg; 2012 Apr 05; 41(4):874-9. PubMed ID: 22423060
    [Abstract] [Full Text] [Related]

  • 38. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE, Redwine J, Foster C, Abella E, Lown T, Lau D, Follette D.
    J Thorac Cardiovasc Surg; 2008 Mar 05; 135(3):615-9. PubMed ID: 18329480
    [Abstract] [Full Text] [Related]

  • 39. Systematic endoscopic staging of mediastinum to guide radiotherapy planning in patients with locally advanced non-small-cell lung cancer (SEISMIC): an international, multicentre, single-arm, clinical trial.
    Steinfort DP, Kothari G, Wallace N, Hardcastle N, Rangamuwa K, Dieleman EMT, Lee P, Li P, Simpson JA, Yo S, Bashirdazeh F, Nguyen P, Jennings BR, Fielding D, Crombag L, Irving LB, Yasufuku K, Annema JT, Ost DE, Siva S.
    Lancet Respir Med; 2024 Jun 05; 12(6):467-475. PubMed ID: 38490228
    [Abstract] [Full Text] [Related]

  • 40. Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
    Nadarevic T, Giljaca V, Colli A, Fraquelli M, Casazza G, Miletic D, Štimac D.
    Cochrane Database Syst Rev; 2021 Oct 06; 10(10):CD013362. PubMed ID: 34611889
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 57.